The difference in the risk of hypothyroidism between anti-PD-1 and anti-PD-L1 mAbs was not statistically significant (OR, 0.53; 95% CI, 0.29–0.96; adjusted p = 0 .11). Here, CD274 is linked to hypothyroidism.